Gamida Cell

Gamida CellGamida Cell
Gamida Cell

Gamida Cell

Biotechnology company developing potentially curative cell therapies for cancer patients.

1998Active
Rate

About

Gamida Cell is a clinical-stage biopharmaceutical company focused on developing potentially curative cell therapies for patients with hematologic malignancies and solid tumors. Their proprietary NAM technology expands the number of cells while maintaining their intrinsic properties, aiming to create more effective and accessible cell therapies.

Technology stack

detected 2026-06-28
EmailMimecast
gateway-fronted
Hosting
Google Cloud
Stack
jQueryBootstrapWordPress
Analytics
Google Analytics 4
Cookie consent
Termly
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Gamida Cell do?

Gamida Cell is a clinical-stage biopharmaceutical company focused on developing potentially curative cell therapies for patients with hematologic malignancies and solid tumors. Their proprietary NAM technology expands the number of cells while maintaining their intrinsic properties, aiming to create more effective and accessible cell therapies.

How much funding has Gamida Cell raised?

Gamida Cell has raised a total of $297M in funding. The most recent round on record is Post-IPO.

Where is Gamida Cell headquartered?

Gamida Cell is headquartered in Boston, United States.

When was Gamida Cell founded?

Gamida Cell was founded in 1998.

What industry does Gamida Cell operate in?

Gamida Cell operates in Life Sciences, Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.